GlassScriptPhysician profile
Lisa F Wolfe
NPI 1336166800
$2,640.53
in general payments reported to CMS, 2019-2025
12 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,099 · 2020: $321 · 2022: $17.74 · 2024: $39.06 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $202.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $1,634.54 | 2019 | |
| Fisher & Paykel Healthcare INC | $346.92 | 2019-2020 | |
| Philips North America LLC | $164.63 | 2019-2024 | (Ak6) Vest Therapy |
| Biogen, INC. | $118.03 | 2025 | Qalsody |
| Genzyme Corporation | $96.13 | 2019 | |
| Sunovion Pharmaceuticals INC. | $95.04 | 2019 | |
| Advanced Respiratory, INC | $46.96 | 2019 | |
| 3b Medical, INC. | $45.52 | 2025 | Luna |
| Hill-Rom Company, INC | $38.95 | 2019 | |
| Glaxosmithkline, LLC. | $36.07 | 2019 | |
| Optinose US, INC. | $17.74 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.